In 2021, prescription medicines in Japan accounted for around 92 percent of the total drug production value in Japan. The rest of approximately eight percent was generated by other medicines such as over-the-counter (OTC) medicines and household medicines, which are stored and kept at home.
Distribution of the pharmaceutical drug production value in Japan from 2012 to 2021, by type
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Japan
Overview
4
- Premium Statistic Global pharmaceutical market - revenue distribution 2010-2021, by region
- Premium Statistic Number of medical drug manufacturing plants Japan 2021, by production value
- Premium Statistic Total asset of major companies in pharmaceutical industry Japan 2021
- Premium Statistic Volume share of generics in prescription drug market Japan 2005-2021
Production
5
- Premium Statistic Production value of pharmaceutical drugs Japan 2012-2021
- Premium Statistic Share of drug production value Japan 2012-2021, by type
- Premium Statistic Share of drug production value Japan 2021, by category
- Premium Statistic Share of drug production value Japan 2021, by drug form
- Premium Statistic Production value of prescription drugs Japan 2012-2021
International trade
4
- Premium Statistic Value of imported pharmaceutical drugs to Japan 2012-2021
- Premium Statistic Value of exported pharmaceutical drugs from Japan 2012-2021
- Premium Statistic Value of imported pharmaceutical drugs to Japan 2021, by region
- Premium Statistic Value of exported pharmaceutical drugs from Japan 2021, by region
Sales
5
- Premium Statistic Prescription and OTC drug wholesales share in Japan FY 1990-2020
- Premium Statistic Prescription drug market size Japan 2002-2021
- Premium Statistic Share of prescription drug sales Japan FY 2011-2020, by channel
- Premium Statistic Share of prescription drug market Japan 2010-2019 , by category
- Premium Statistic Sales value of leading drugs Japan FY 2021
Expenditure
4
- Premium Statistic R&D spending of pharmaceutical companies in relation to sales Japan FY 2015-2021
- Premium Statistic R&D spending of pharmaceutical companies Japan FY 2015-2021
- Premium Statistic R&D expenditure of leading pharmaceutical manufacturers Japan 2020
- Premium Statistic Ad expenses of the pharmaceuticals industry Japan 2012-2021
Approval and patent
5
- Premium Statistic Number of pharmaceutical products approved by PMDA Japan FY 2020, by type
- Premium Statistic Number of prescription drugs approved by PMDA Japan FY 2015-2020, by type
- Premium Statistic Number of new drugs approved by PMDA Japan FY 2014-2020
- Premium Statistic Number of patents in the pharmaceutical industry Japan 2021, by type
- Premium Statistic Companies with the highest number of pharmaceutical patent applications Japan 2021
Leading companies
6
- Premium Statistic Major pharmaceutical companies in prescription drug sales Japan 2021, by distributor
- Premium Statistic Net sales of leading generics makers Japan 2020
- Basic Statistic Takeda Pharmaceutical's revenue FY 2012-2021
- Basic Statistic Otsuka Holdings' net sales FY 2012-2021
- Basic Statistic Astellas Pharma's revenue FY 2012-2021
- Basic Statistic Daiichi Sankyo's revenue FY 2012-2021
Coronavirus (COVID-19)
3
Further related statistics
19
- Global pharmaceutical pipeline by therapy area 2013-2017
- Pharmaceutical drug production value Japan 2018, by prefecture
- Global pharmaceutical product launches by therapy area 2004-2013
- Median duration of drug shortages in Canada 2013-2016
- U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Expenditure worldwide on diabetes by market 2013-2018
- List price and rebate price change of select top drugs US 2009-2015
- Employment in the pharmaceuticals manufacturing industry in Poland 2015-2019
- Pharmaceutical products production in Poland 2005-2021
- Most prescribed brand name drugs in Italy December 2021, by sales value
- Leading specialty therapy areas in the U.S. by PMPY spending 2020
- Drugs or pharmaceuticals products frequently purchased online in Spain 2014
- Canadian pharmaceutical exports and imports 2004-2020
- Top U.S. proton pump inhibitors' revenue market share 2013
- Sold production of pharmaceutical products in Poland 2015-2022
- Revenue per capita of OTC pharmaceuticals in Singapore 2016-2027
- Manufacture of pharmaceutical preparations revenue in Belgium 2010-2022
- Revenue per capita of OTC pharmaceuticals in the Philippines 2016-2027
- Italy: monthly value of human blood imports into 2017-2018
Further Content: You might find this interesting as well
Statistics
- Global pharmaceutical pipeline by therapy area 2013-2017
- Pharmaceutical drug production value Japan 2018, by prefecture
- Global pharmaceutical product launches by therapy area 2004-2013
- Median duration of drug shortages in Canada 2013-2016
- U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Expenditure worldwide on diabetes by market 2013-2018
- List price and rebate price change of select top drugs US 2009-2015
- Employment in the pharmaceuticals manufacturing industry in Poland 2015-2019
- Pharmaceutical products production in Poland 2005-2021
- Most prescribed brand name drugs in Italy December 2021, by sales value
- Leading specialty therapy areas in the U.S. by PMPY spending 2020
- Drugs or pharmaceuticals products frequently purchased online in Spain 2014
- Canadian pharmaceutical exports and imports 2004-2020
- Top U.S. proton pump inhibitors' revenue market share 2013
- Sold production of pharmaceutical products in Poland 2015-2022
- Revenue per capita of OTC pharmaceuticals in Singapore 2016-2027
- Manufacture of pharmaceutical preparations revenue in Belgium 2010-2022
- Revenue per capita of OTC pharmaceuticals in the Philippines 2016-2027
- Italy: monthly value of human blood imports into 2017-2018
MHLW (Japan). (December 23, 2022). Distribution of the pharmaceutical drug production value in Japan from 2012 to 2021, by type [Graph]. In Statista. Retrieved May 28, 2023, from https://www.statista.com/statistics/1108415/japan-share-drug-production-value-by-type/
MHLW (Japan). "Distribution of the pharmaceutical drug production value in Japan from 2012 to 2021, by type." Chart. December 23, 2022. Statista. Accessed May 28, 2023. https://www.statista.com/statistics/1108415/japan-share-drug-production-value-by-type/
MHLW (Japan). (2022). Distribution of the pharmaceutical drug production value in Japan from 2012 to 2021, by type. Statista. Statista Inc.. Accessed: May 28, 2023. https://www.statista.com/statistics/1108415/japan-share-drug-production-value-by-type/
MHLW (Japan). "Distribution of The Pharmaceutical Drug Production Value in Japan from 2012 to 2021, by Type." Statista, Statista Inc., 23 Dec 2022, https://www.statista.com/statistics/1108415/japan-share-drug-production-value-by-type/
MHLW (Japan), Distribution of the pharmaceutical drug production value in Japan from 2012 to 2021, by type Statista, https://www.statista.com/statistics/1108415/japan-share-drug-production-value-by-type/ (last visited May 28, 2023)
Distribution of the pharmaceutical drug production value in Japan from 2012 to 2021, by type [Graph], MHLW (Japan), December 23, 2022. [Online]. Available: https://www.statista.com/statistics/1108415/japan-share-drug-production-value-by-type/